Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mannatech Direct-Selling Model Artificially Inflated Stock Price – Lawsuit

This article was originally published in The Tan Sheet

Executive Summary

At least two class-action lawsuits have been filed against dietary supplement marketer Mannatech, alleging the firm misled investors about its growth potential by inaccurately describing how it monitors associates who participate in its direct-selling program

You may also be interested in...



Texas AG Files Suit Alleging Mannatech Uses False Claims In Marketing

Texas Attorney General Greg Abbott has filed a lawsuit seeking to shut down Mannatech, but the firm's executives advise their multi-level marketing associates to continue conducting business as usual, predicting a "marathon" in defending the suit

Texas AG Files Suit Alleging Mannatech Uses False Claims In Marketing

Texas Attorney General Greg Abbott has filed a lawsuit seeking to shut down Mannatech, but the firm's executives advise their multi-level marketing associates to continue conducting business as usual, predicting a "marathon" in defending the suit

Texas AG Files Suit Alleging Mannatech Uses False Claims In Marketing

Texas Attorney General Greg Abbott has filed a lawsuit seeking to shut down Mannatech, but the firm's executives advise their multi-level marketing associates to continue conducting business as usual, predicting a "marathon" in defending the suit

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098654

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel